Pfizer to merge off-patent business with Mylan

30 July 2019 - Deborah Wilkes

Pfizer has announced plans to merge its off-patent pharmaceutical business Upjohn with generics company Mylan. The deal includes Mylan's OTC products with sales in excess of USD1 billion.